Cost effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screening.

abstract：BACKGROUND:European guidelines advocate the measurement of on-treatment hepatitis C virus (HCV) RNA in order to determine optimal therapy duration (response-guided therapy [RGT]) in patients with rapid virological response (RVR) or delayed virological response (DVR). Treatment response is highly dependent upon the exte...

journal_title：Applied health economics and health policy

authors： McEwan P,Kim R,Yuan Y

更新日期：2013-02-01 00:00:00

abstract：:There is wide consensus that the ways in which providers are reimbursed by third parties will affect their behaviour and, hence, the efficient use of limited resources and the performance of health systems. However, there seems to be little evidence on how payment to hospital-based doctors affects hospital performance...

journal_title：Applied health economics and health policy

authors： Liu X,Mills A

更新日期：2003-01-01 00:00:00

abstract：:This paper examines the use of propensity score matching in economic analyses of observational data. Several excellent papers have previously reviewed practical aspects of propensity score estimation and other aspects of the propensity score literature. The purpose of this paper is to compare the conceptual foundation...

journal_title：Applied health economics and health policy

authors： Crown WH

更新日期：2014-02-01 00:00:00

abstract：:This paper reconsiders the evidence and several of the key arguments associated with the theory of supplier-induced demand (SID). It proposes a new theory to explain how ethical behaviour is consistent with SID. The purpose of a theory of demand and one criterion for the evaluation of a theory is the provision of a pl...

journal_title：Applied health economics and health policy

authors： Richardson JR,Peacock SJ

更新日期：2006-01-01 00:00:00

abstract：:Healthcare reforms aim to change certain parts of the health system to improve quality of care, access, or financial sustainability. Traditionally, healthcare reform is understood as an action undertaken by a government at a national or local level. However, bottom-up changes can also lead to improvements in the healt...

journal_title：Applied health economics and health policy

authors： Selgas R,Rodriguez L,Julian JC,Remon C,Prieto-Velasco M,Perez-Contreras J,Fontan MP,GADDPE.

更新日期：2017-12-01 00:00:00

abstract：BACKGROUND:Cervical cancer ranks fourth amongst the commonest malignancies worldwide and the second most prevalent cancer afflicting women in low-to-middle income countries (LMICs), hence, of great public health importance. LMICs are the most affected regions as evidenced by their high prevalence of the disease. Mortal...

journal_title：Applied health economics and health policy

authors： Okeah BO,Ridyard CH

更新日期：2020-10-01 00:00:00

abstract：BACKGROUND:Although the costs of treating inflammatory bowel disease (IBD) in developed countries are well established, they remain largely unknown in countries with recent histories of socio-economic transition including Serbia. OBJECTIVE:To estimate the costs of treatment including the resources used by patients wit...

journal_title：Applied health economics and health policy

authors： Kostić M,Djakovic L,Šujić R,Godman B,Janković SM

更新日期：2017-02-01 00:00:00

abstract：BACKGROUND:The Xpert® MTB/RIF (Xpert) test has been shown to be effective and cost-effective for diagnosing tuberculosis (TB) under conditions with high HIV prevalence and HIV-TB co-infection but less is known about Xpert's cost in low HIV prevalence settings. Cambodia, a country with low HIV prevalence (0.7%), high TB...

journal_title：Applied health economics and health policy

authors： Pallas SW,Courey M,Hy C,Killam WP,Warren D,Moore B

更新日期：2018-08-01 00:00:00

abstract：:Blockchain technology is a decentralized database that stores a registry of assets and transactions across a peer-to-peer computer network, which is secured through cryptography, and over time, its history gets locked in blocks of data that are cryptographically linked together and secured. So far, there have been use...

journal_title：Applied health economics and health policy

authors： Radanović I,Likić R

更新日期：2018-10-01 00:00:00

abstract：:The aim of the review is to establish whether, on the basis of previous published evidence, current accepted guidance for health economic evaluation needs to be adapted to evaluate healthcare based on use of genetic information. Online literature search strategies were designed (using PubMed and the NHS Economic Evalu...

journal_title：Applied health economics and health policy

authors： Jarrett J,Mugford M

更新日期：2006-01-01 00:00:00

abstract：:Central venous catheters are commonly used to deliver therapies and to monitor patients, and require securing at the point of percutaneous entry to avoid dislodgement. SecurAcath is a catheter securement device designed for central venous catheters. The National Institute for Health and Care Excellence, as a part of i...

journal_title：Applied health economics and health policy

authors： Macmillan T,Pennington M,Summers JA,Goddard K,Zala D,Herz N,Peacock JL,Keevil S,Chalkidou A

更新日期：2018-12-01 00:00:00

abstract：BACKGROUND:Chronic obstructive pulmonary disease (COPD) affects approximately 3 million people in the UK. An 8-week pulmonary rehabilitation (PR) course is recommended under current guidelines. However, studies show that initial benefits diminish over time. OBJECTIVE:We present here an economic evaluation conducted al...

journal_title：Applied health economics and health policy

authors： Burns DK,Wilson EC,Browne P,Olive S,Clark A,Galey P,Dix E,Woodhouse H,Robinson S,Wilson A

更新日期：2016-02-01 00:00:00

abstract：BACKGROUND:Immunization rates for human papillomavirus (HPV) infections remain low among teenagers despite strong evidence of the effectiveness of vaccines. Physician recommendations of the vaccine are far from universal. Several states have enacted policies that mandate HPV vaccination or distribute educational materi...

journal_title：Applied health economics and health policy

authors： Moghtaderi A,Adams S

更新日期：2016-06-01 00:00:00

abstract：BACKGROUND:Price, income and health status are likely to affect the demand for healthcare in developing countries, and their quantitative effects are unclear in the literature. Some studies report that prices are not important determinants, while others conclude that prices are important determinants of the demand for ...

journal_title：Applied health economics and health policy

authors： Sarma S

更新日期：2009-01-01 00:00:00

abstract：BACKGROUND:Although suicide-prevention campaigns have been implemented in numerous countries, Canada has yet to implement a strategy nationally. This is the first study to examine the cost utility of the implementation of a multidimensional suicide-prevention program that combines several interventions over a 50-year t...

journal_title：Applied health economics and health policy

authors： Lebenbaum M,Cheng J,de Oliveira C,Kurdyak P,Zaheer J,Hancock-Howard R,Coyte PC

更新日期：2020-04-01 00:00:00

abstract：BACKGROUND:In Slovenia during the period 2000-2010, the number of years of potential life lost before the age of 70 years per 100,000 population under 70 years of age declined 25 %. OBJECTIVE:The aim of this study was to test the hypothesis that pharmaceutical innovation played a key role in reducing premature mortali...

journal_title：Applied health economics and health policy

authors： Lichtenberg FR

更新日期：2015-04-01 00:00:00

abstract：BACKGROUND:Cost-effectiveness analyses (CEAs) have been performed for oral non-disease-altering osteoarthritis (OA) treatments for well over a decade. During that period the methods for performing these analyses have evolved as pharmacoeconomic methods have advanced, new treatments have been introduced, and the knowled...

journal_title：Applied health economics and health policy

authors： Wielage RC,Myers JA,Klein RW,Happich M

更新日期：2013-12-01 00:00:00

abstract：BACKGROUND:Pricing drugs in the California Workers' Compensation System (CAWCS) has become more difficult as there are increasingly fewer drugs listed in the Medi-Cal primary fee schedule, which is used as the source for CAWCS drug prices. This presents a challenge of providing timely and accurate CAWCS reimbursement. ...

journal_title：Applied health economics and health policy

authors： Wilson L,Turkistani F,Tran DM,Huang W,Lin TK

更新日期：2019-04-01 00:00:00

abstract：:The debate surrounding whether the findings of efficacy studies are applicable to real-world treatment situations is ongoing. The issue of lack of applicability due to a lack of clinical heterogeneity could be addressed by employing less restrictive inclusion criteria. Given that health economic assessments based on c...

journal_title：Applied health economics and health policy

authors： Richter A,Thieda P,Thaler K,Gartlehner G

更新日期：2011-05-01 00:00:00

abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is the second most common cancer in Taiwan. For males in Taiwan, it is the most dangerous cancer, with both the highest incidence and mortality rate. OBJECTIVE:To determine cancer-related medical care costs for long-term survivors of HCC. METHODS:The estimation of the lifetim...

journal_title：Applied health economics and health policy

authors： Lang HC,Wu JC,Yen SH,Lan CF,Wu SL

更新日期：2008-01-01 00:00:00

abstract：:Payment incentives to both consumers and providers have significant consequences for the equity and efficiency of a healthcare system, and have recently come to the fore in health policy reforms. This review first discusses the economic rationale for the apparent international convergence toward payment systems with m...

journal_title：Applied health economics and health policy

authors： Eggleston K,Hsieh CR

更新日期：2004-01-01 00:00:00

abstract：:A routine part of the process for developing National Institute for Health and Care Excellence (NICE) medical technologies guidance is a submission of clinical and economic evidence by the technology manufacturer. The Birmingham and Brunel Consortium External Assessment Centre (EAC; a consortium of the University of B...

journal_title：Applied health economics and health policy

authors： Higgins A,Glover M,Yang Y,Bayliss S,Meads C,Lord J

更新日期：2014-10-01 00:00:00

abstract：OBJECTIVES:The objective of the present work was to assess the level of evidence in economic evaluations of percutaneous left atrial appendage closure devices, and to test the complementarity of three different tools for assessing the quality of economic evaluations. METHODS:We conducted a systematic review of article...

journal_title：Applied health economics and health policy

authors： Nédellec E,Pineau J,Prognon P,Martelli N

更新日期：2018-12-01 00:00:00

abstract：:Economic models are developed to provide decision makers with information related to the real-world effectiveness of therapeutics, screening and diagnostic regimens. Although compliance with these regimens often has a significant impact on real-world clinical outcomes and costs, compliance and persistence have histori...

journal_title：Applied health economics and health policy

authors： Kadambi A,Leipold RJ,Kansal AR,Sorensen S,Getsios D

更新日期：2012-11-01 00:00:00

abstract：BACKGROUND:Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Little is known about the economic burden associated with PAH patients in the US. OBJECTIVES:The objective of this study was to estimate excess direct costs associated with privately insured PAH patients in the US. METHODS:From a privately ...

journal_title：Applied health economics and health policy

authors： Kirson NY,Birnbaum HG,Ivanova JI,Waldman T,Joish V,Williamson T

更新日期：2011-09-01 00:00:00

abstract：OBJECTIVES:Invasive pneumococcal disease (IPD), pneumonia and acute otitis media (AOM) still represent a significant medical burden in children < 5 years of age in New Zealand (NZ), with marked disparities across socio-economic and ethnic groups. This cost-effectiveness evaluation aims to compare the potential impact o...

journal_title：Applied health economics and health policy

authors： Varghese L,Talbot L,Govender A,Zhang XH,Mungall BA

更新日期：2018-06-01 00:00:00

abstract：:The mandatory nature of recommendations made by the National Institute for Health and Clinical Excellence (NICE) in the UK has highlighted inherent difficulties in the process of disinvestment in existing technologies to fund NICE-approved technologies. A lack of evidence on candidate technologies means that the proce...

journal_title：Applied health economics and health policy

authors： Karnon J,Carlton J,Czoski-Murray C,Smith K

更新日期：2009-01-01 00:00:00

abstract：BACKGROUND:There is obscurity regarding how US hospitals determine patients' charges. Whether insurance status influences a patient's hospital charge has not been explored. OBJECTIVE:The objective of this study was to determine whether hospitals charge patients differently based on their insurance status. METHODS:Thi...

journal_title：Applied health economics and health policy

authors： Woodworth L,Romano PS,Holmes JF

更新日期：2017-06-01 00:00:00

abstract：BACKGROUND:Low back pain (LBP) is a major health problem, having a substantial effect on peoples' quality of life and placing a significant economic burden on healthcare systems and, more broadly, societies. Many interventions to alleviate LBP are available but their cost effectiveness is unclear. OBJECTIVES:To identi...

journal_title：Applied health economics and health policy

authors： Andronis L,Kinghorn P,Qiao S,Whitehurst DG,Durrell S,McLeod H

更新日期：2017-04-01 00:00:00

abstract：:The South Korean Government recently announced a reform in the drug anti-rebate law, with the purpose of eradicating pervasive, unethical, and illegal rebate practices in pharmaceutical marketing. The main objective of this reform is to have the ability to bring criminal charges against doctors and pharmacists for rec...

journal_title：Applied health economics and health policy

authors： Yu SY,Yang BM,Kim JH

更新日期：2013-08-01 00:00:00